000 01560 a2200385 4500
005 20250515194716.0
264 0 _c20110304
008 201103s 0 0 eng d
022 _a1742-1241
024 7 _a10.1111/j.1742-1241.2009.02189.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStaskin, D R
245 0 0 _aTrospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
_h[electronic resource]
260 _bInternational journal of clinical practice
_cDec 2009
300 _a1715-23 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aBenzilates
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscarinic Antagonists
_xadministration & dosage
650 0 4 _aNortropanes
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aUrinary Bladder, Overactive
_xdrug therapy
700 1 _aRosenberg, M T
700 1 _aSand, P K
700 1 _aZinner, N R
700 1 _aDmochowski, R R
773 0 _tInternational journal of clinical practice
_gvol. 63
_gno. 12
_gp. 1715-23
856 4 0 _uhttps://doi.org/10.1111/j.1742-1241.2009.02189.x
_zAvailable from publisher's website
999 _c19315176
_d19315176